Corporate | 5 December 2008 06:49
NEW VALUE AG / Miscellaneous
Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Information on New Value’s portfolio company Bogar AG
Bogar AG boosts its capital by CHF 7 million
Bogar AG of Wallisellen (Switzerland), a New Value portfolio company active
in the animal health and nutrition industry, successfully increased its
capital at the end of November by CHF 7 million. The newly subscribed
capital was received in cash and by conversion of existing loans. New Value
subscribed to CHF 2.2 million, increasing its share in the equity of Bogar
AG from 16.6% to 29.8%. The new financial resources will be used to
consistently pursue the company’s growth strategy, expand existing
distribution channels, and drive the development of new products.
The current fiscal year 2008 is developing into another record year. Sales
will again double compared to the previous year. The tick repellant for
dogs and the newly introduced tick repellant for cats are selling
particularly well. Both products are based on innovative combinations of
natural active ingredients derived from specially selected plants. The
decisive factors for the success of these products are primarily the
consistent orientation of the product portfolio to customer requirements,
new sales partnerships in Switzerland and Germany, and an optimized, lean
organizational structure. To prolong the growth strategy next year, Bogar
undertook a capital increase of CHF 7 million. New Value subscribed to
roughly one third of the increase by conversion of existing loans in the
amounts of CHF 1.9 million and 0.3 million in cash, leading to a
significant increase of its stake in the company from 16.6% to 29.8%.
InCentive Holding AG and private investors provided the rest of the
financing.
Expansion of market presence in Switzerland, Germany and Austria
Marketing efforts will focus again in 2009 on the DACH region, in which
further expansion of market presence is targeted. Bogar products will be
sold in 2009 in Switzerland by Qualipet, Sun Store and Manor, among others,
and in Germany by Trixie Heimtierbedarf, ARAS Tiernahrung, alfavet
Tierarzneimittel, and Heiland. In parallel with this, marketing activities
in Austria will be intensified. Active entry into additional markets is
planned for 2010. In addition to major specialty store outlets, pharmacies
will be used increasingly as a distribution channel. The current portfolio
encompasses 19 products for dogs, cats, and horses. Additional product
launches from the company’s proprietary development pipeline are planned
for next year. For example, intensive effort is currently being devoted to
the formulation of a new line of shampoos. All new products will conform to
Bogar’s proven high quality, effectiveness of existing preparations, and
standards of innovation.
About Bogar
Bogar specializes in natural animal health and nutrition and develops,
produces, and markets quality plant-based food supplements and care
products. Bogar has acted as a pioneer, especially in the field of
veterinary phytotherapy, and has developed a continuously expanding range
of products for effective nutritional supplementation and natural
prevention and treatment of various psychological and somatic disorders and
diseases in pets and domestic animals.
Information about New Value AG
New Value, officially listed at the SIX Swiss Exchange, invests directly in
promising private companies in Switzerland and neighbouring German-speaking
countries with above-average market and growth potential. As an investment
company, New Value promotes innovative business models with venture capital
and accompanies those to market success. The portfolio covers companies of
different stages of development, starting with the market introduction
phase up to medium-sized enterprises with stable profits. A broad
investment approach is deliberately followed regarding industry sectors.
The portfolio contains companies active in renewable energy, medical
technology, health, information technology and new materials. New Value
assigns great value to ethical business concepts and good corporate
governance while selecting their portfolio companies. Criteria such as
meaningfulness, social responsibility and ecological sustainability are
considered by New Value as decisive competitive advantages, which affect
and enhance the quality of products and services offered and thus,
facilitate an above average increase of value potential. Since the
formation of New Value, EPS Value Plus AG, Zurich, has served as investment
manager.
05.12.2008 Financial News transmitted by DGAP
----------------------------------------------------------------------
Language: English
Issuer: NEW VALUE AG
Bodmerstrasse 9
8027 Zürich
Schweiz
Phone: +41-43-344 38 38
Fax: +41-43-344 38 39
E-mail: info@newvalue.ch
Internet: www.newvalue.ch
ISIN: CH0010819867
WKN: 552932
Listed: Freiverkehr in Berlin, Stuttgart, München, Düsseldorf; Open
Market in Frankfurt; Foreign Exchange(s) SWX
End of News DGAP News-Service
---------------------------------------------------------------------------